LS
PCRX icon

Lupo Securities’s Pacira BioSciences PCRX Stock Holding History

Lupo Securities’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$55K Buy
1,350
+1,300
+2,600% +$79.6K 0.41% 30
2015
Q2 		$4K Buy
+50
New +$3.94K 0.02% 82

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lupo Securities's PCRX Position: Q3 2015 in Review

Lupo Securities increased its Pacira BioSciences (PCRX) stake by 2,600% in Q3 2015, buying an estimated $79.6K and bringing the position to 1,350 shares worth $55K. The position accounts for 0.41% of the portfolio, ranked #30.

Lupo Securities first reported a position in PCRX in Q2 2015 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold PCRX as of Q3 2015.

  • Lupo Securities held 1,350 shares of Pacira BioSciences worth $55K as of Q3 2015.
  • Lupo Securities bought 1,300 Pacira BioSciences shares in Q3 2015, an estimated $79.6K.
  • Pacira BioSciences made up 0.41% of Lupo Securities's portfolio in Q3 2015, its #30 holding.
  • Lupo Securities first reported a position in Pacira BioSciences in Q2 2015 and has held it in 2 quarters since.
  • 177 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.